Cell Discovery

Papers
(The H4-Index of Cell Discovery is 44. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
Generation of live mice from haploid ESCs with germline-DMR deletions or switch200
Biogenesis of Rab14-positive endosome buds at Golgi–endosome contacts by the RhoBTB3–SHIP164–Vps26B complex166
Structural basis of a two-antibody cocktail exhibiting highly potent and broadly neutralizing activities against SARS-CoV-2 variants including diverse Omicron sublineages144
Molecular mechanisms of urate transport by the native human URAT1 and its inhibition by anti-gout drugs138
Structural insights into neurokinin 3 receptor activation by endogenous and analogue peptide agonists107
Safety and feasibility of anti-CD19 CAR T cells expressing inducible IL-7 and CCL19 in patients with relapsed or refractory large B-cell lymphoma105
A spatiotemporal transcriptomic atlas of mouse placentation102
Human zygotic genome activation is initiated from paternal genome93
Precision modeling of mitochondrial diseases in zebrafish via DdCBE-mediated mtDNA base editing84
Dynamic 3D genome reorganization during development and metabolic stress of the porcine liver79
Spermidine-eIF5A axis is essential for muscle stem cell activation via translational control75
Hypercompact TnpB and truncated TnpB systems enable efficient genome editing in vitro and in vivo74
Historical loss weakens competitive behavior by remodeling ventral hippocampal dynamics74
Structural characterization reveals substrate recognition by the taurine transporter TauT72
Developing an erythrocyte‒MHC-I conjugate for cancer treatment72
A phosphorylation switch in the Mediator MED15 controls cellular senescence and cognitive decline70
Combating the SARS-CoV-2 Omicron (BA.1) and BA.2 with potent bispecific antibodies engineered from non-Omicron neutralizing antibodies65
The building blocks of embryo models: embryonic and extraembryonic stem cells64
Author Correction: Single-cell and spatial proteo-transcriptomic profiling reveals immune infiltration heterogeneity associated with neuroendocrine features in small cell lung cancer64
RBBP6 maintains glioblastoma stem cells through CPSF3-dependent alternative polyadenylation63
Structural insight into how WDR4 promotes the tRNA N7-methylguanosine methyltransferase activity of METTL162
Interplay between ADP-ribosyltransferases and essential cell signaling pathways controls cellular responses61
TMEM151A variants cause paroxysmal kinesigenic dyskinesia61
Structural insight into PIF6-mediated red light signal transduction of plant phytochrome B61
Integrated compact regulators of protein activity enable control of signaling pathways and genome-editing in vivo60
Coronary vessels contribute to de novo endocardial cells in the endocardium-depleted heart59
Molecular architecture and gating mechanisms of the Drosophila TRPA1 channel58
Author Correction: Coronary vessels contribute to de novo endocardial cells in the endocardium-depleted heart56
A trifunctional peptide broadly inhibits SARS-CoV-2 Delta and Omicron variants in hamsters53
Heat shock protein DNAJA2 regulates transcription-coupled repair by triggering CSB degradation via chaperone-mediated autophagy52
Structures and comparison of endogenous 2-oxoglutarate and pyruvate dehydrogenase complexes from bovine kidney51
Heterologous prime-boost immunizations with chimpanzee adenoviral vectors elicit potent and protective immunity against SARS-CoV-2 infection51
Host susceptibility and structural and immunological insight of S proteins of two SARS-CoV-2 closely related bat coronaviruses49
Packaged release and targeted delivery of cytokines by migrasomes in circulation48
Mechanistic insights into the acetyl-CoA recognition by SLC33A148
Reprogramming an RNA-guided archaeal TnpB endonuclease for genome editing48
Author Correction: A broader neutralizing antibody against all the current VOCs and VOIs targets unique epitope of SARS-CoV-2 RBD48
COVID-19 vaccination boosts the potency and breadth of the immune response against SARS-CoV-2 among recovered patients in Wuhan47
Molecular recognition of the atypical chemokine-like peptide GPR15L by its cognate receptor GPR1546
RhoA-mediated G12-G13 signaling maintains muscle stem cell quiescence and prevents stem cell loss46
Structural basis for the activity regulation of Medicago calcium channel CNGC1544
Trans-Golgi network tethering factors regulate TBK1 trafficking and promote the STING-IFN-I pathway44
Bivalent mRNA vaccine booster induces robust antibody immunity against Omicron lineages BA.2, BA.2.12.1, BA.2.75 and BA.544
Dynamics of TCR repertoire and T cell function in COVID-19 convalescent individuals44
0.74885892868042